Adjuvant Lipoic acid Injection in Sepsis treatment in China (ALIS study): protocol for a randomised, single-blind, placebo-controlled trial

INTRODUCTION: Sepsis is a life-threatening immune disorder resulting from an dysregulated host response to infection. Adjuvant therapy is a valuable complement to sepsis treatment. Lipoic acid has shown potential in attenuating sepsis-induced immune dysfunction and organ injury in vivo and in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Linhui, Zhou, Xinjuan, Huang, Jinbo, He, Yuemei, Wu, Quanzhong, Huang, Xiangwei, Wu, Kunyong, Wang, Guangwen, Li, Sinian, Chen, Xiangyin, Chen, Chunbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387639/
https://www.ncbi.nlm.nih.gov/pubmed/37518088
http://dx.doi.org/10.1136/bmjopen-2023-072897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387639/
https://www.ncbi.nlm.nih.gov/pubmed/37518088
http://dx.doi.org/10.1136/bmjopen-2023-072897

Ejemplares similares